About Monolom India Pharma Private Limited
Data last updated: 11 January 2026
Monolom India Pharma Private Limited is a foreign private limited company based in Pune, Maharashtra, India, a subsidiary of Wavelength Enterprises Limited. It specialises in pharma contract r and d, a part of the broader pharmaceuticals sector. Incorporated on 27 October 2017, the company has been in operation for over 9 years.
Registered with ROC Pune under CIN U24303MH2017FTC301208.
Capital: an authorised share capital of ₹5.3 Cr and a paid-up capital of ₹3.44 Cr. It is led by directors including Chiara Bergerone and Ben Zion Dolitzky.
Last AGM: 30 September 2025. Financial statements filed for year ended 31 March 2025. Office: 15 Intl Biotech Park, Pune, Maharashtra.
As per the financials filed for FY 2025, the company reported a revenue of ₹18.17 Cr, a decline of 1% compared to the previous year.
The company has a workforce of approximately 39 employees as per the latest available data. It operates as a subsidiary of Wavelength Enterprises Limited.
The company is associated with 2 brands - Wavelength Pharmaceuticals, Seqens. As per MCA filings, the company has open charges of ₹50,000 on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website wavelengthpharma.com.
-
EmailLocked
-
TelephoneLocked
-
WebsiteLocked
-
Social Media
-
Registered AddressNo.1 – 7&12 – 17 3 Floor Genesis Square Plot No.15 Intl Biotech Park Midc Phase 2 Rg It Bt, Park Maan, Pune, Maharashtra, India – 411057
-
IndustryPharma, Pharma Contract R&D
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
CIN History of Monolom India Pharma Private Limited
Monolom India Pharma Private Limited has one previous CIN (Corporate Identification Number): U24303MH2017FTC301208. The current CIN is U24303PN2017FTC188118, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24303PN2017FTC188118 | Current |
| U24303MH2017FTC301208 | Previous |
Associated Brands with Monolom India Pharma Private Limited
Monolom India Pharma Private Limited operates two associated brands: Wavelength Pharmaceuticals and Seqens. These brands represent Monolom India Pharma Private Limited's diversified market presence and brand portfolio.
| Brand | Description | Website |
|---|---|---|
| APIs and finished dosage forms are manufactured for therapeutic categories. | wavelengthpharma.com | |
| Contract manufacturing services for small molecules and peptides are provided. | seqens.com |
Competitors & Alternatives of Monolom India Pharma Private Limited
Brands and companies operating in the same space as Monolom India Pharma Private Limited include Concord Biotech, BDR Pharmaceuticals Internationals, Almac Group and 7 more.
| Competitor | Description | Location | Founded |
|---|---|---|---|
Concord Biotech
|
APIs and enzymes are manufactured through fermentation by the CDMO. | Ahmedabad, India, India | 2000 |
BDR Pharmaceuticals Internationals
|
APIs and finished products are developed and manufactured. | Mumbai, India, India | 2003 |
Almac Group
|
Integrated CDMO services for biopharma R&D and manufacturing are offered. | Craigavon, United Kingdom, United Kingdom | 2001 |
Indoco Remedies
|
APIs manufacturing and formulation services are provided in therapeutic segments. | Mumbai, India, India | 1947 |
Pharmaceutics International
|
Pharmaceutical dosage forms are manufactured by this CDMO. | Hunt Valley, United States, United States | 1994 |
Aurobindo Pharma
|
Generic biocatalytic solutions are provided for pharmaceutical applications. | Hyderabad, India, India | 1986 |
Asymchem
|
APIs and peptides are developed and manufactured by Asymchem. | Morrisville, United States, United States | 1995 |
Aptuit
|
Contract research and development services for small molecules are offered. | Greenwich, United States, United States | 2004 |
Continuus Pharma
|
MIT-Novartis spinoff offering continuous manufacturing solutions to remove the proverbial wall between API and FDF manufacturing in small molecule development | Woburn, United States, United States | 2012 |
Alcami
|
End-to-end small molecule development and manufacturing are provided for pharmaceuticals. | Wilmington, United States, United States | 2016 |
Business Activity of Monolom India Pharma Private Limited
Monolom India Pharma Private Limited is engaged in the principal business activity of professional, scientific and technical, with detailed activities including scientific research and development.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| M | Professional, Scientific and Technical | M5 | Scientific research and development | Locked |
Business activity turnover details for Monolom India Pharma Private Limited
Turnover contribution percentages and historical activity changes require an active report plan.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Board of Directors of Monolom India Pharma Private Limited
Monolom India Pharma Private Limited is currently managed by 4 directors, with 11 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
|
Chiara Bergerone
Also directs:
Vanamali Organics Private Limited
|
Director | - | Current | |
| Ben Zion Dolitzky | Director | 24 Mar 2023 | 3 Years 3 Months | Current |
| Ashutosh Vijay Joshi | Director | 30 Jun 2025 | 1 Years 0 Months | Current |
| Adrien Aymery Joel Bresson | Director | 22 Jan 2025 | 1 Years 5 Months | Current |
Financials of Monolom India Pharma Private Limited FY 2025 filings available
Monolom India Pharma Private Limited reported revenue of ₹18.17 Cr (down 1.00% YoY) for FY 2025.
Ten-year financial statements for Monolom India Pharma Private Limited
Historical statement values and trend charts require an active report plan.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Charges & Borrowings of Monolom India Pharma Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 23 Nov 2022 | The Hongkong and Shanghai Banking Corporation Limited | ₹50,000 | Open |
Total charge records: 1 View all charges
Employees and EPFO Compliance at Monolom India Pharma Private Limited
View historical data on people associated with Monolom India Pharma Private Limited, including employment history and EPFO contributions.
Employee and EPFO history for Monolom India Pharma Private Limited
Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
GST Compliance of Monolom India Pharma Private Limited
GST registrations and filing compliance for Monolom India Pharma Private Limited
State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
Credit Ratings, Litigation & Regulatory Alerts for Monolom India Pharma Private Limited
Credit ratings, litigation, and regulatory alerts for Monolom India Pharma Private Limited
Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Monolom India Pharma Private Limited
MSME payment history for Monolom India Pharma Private Limited
Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Monolom India Pharma Private Limited
Corporate group structure for Monolom India Pharma Private Limited
Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Monolom India Pharma Private Limited
MCA filings and documents for Monolom India Pharma Private Limited
Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Recent Activity on Monolom India Pharma Private Limited
Frequently Asked Questions about Monolom India Pharma Private Limited
Monolom India Pharma Private Limited is an active foreign private limited company in the pharma sector based in Pune, Maharashtra, India. It was incorporated on 27 October 2017 (9+ years old) and is registered under CIN U24303PN2017FTC188118. The company has 39 employees.
Monolom India Pharma Private Limited reported revenue of ₹18.17 Cr for FY 2025 (down 1.00% YoY).
The current directors of Monolom India Pharma Private Limited are:
- Chiara Bergerone - Director
- Ben Zion Dolitzky - Director
- Ashutosh Vijay Joshi - Director
- Adrien Aymery Joel Bresson - Director
The primary industry of Monolom India Pharma Private Limited is pharma. The company specifically operates in pharma contract r and d. The company is currently active in this sector.
Monolom India Pharma Private Limited can be reached at the registered office: No.1 – 7&12 – 17 3 Floor Genesis Square Plot No.15 Intl Biotech Park Midc Phase 2 Rg It Bt, Park Maan, Pune, Maharashtra, India – 411057, or through the website wavelengthpharma.com.
The authorised capital is ₹5.3 Cr, and the paid-up capital is ₹3.44 Cr.